GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $179 | +188.7% | 93 | +116.3% | 0.00% | – |
Q2 2023 | $62 | – | 43 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 43 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 43 | -100.0% | 0.00% | – |
Q1 2021 | $218,000 | -6.0% | 100,555 | -3.0% | 0.00% | – |
Q4 2020 | $232,000 | +222.2% | 103,713 | +378.5% | 0.00% | – |
Q3 2020 | $72,000 | -15.3% | 21,674 | -22.6% | 0.00% | – |
Q2 2020 | $85,000 | +7.6% | 28,011 | -31.0% | 0.00% | – |
Q1 2020 | $79,000 | +107.9% | 40,599 | +209.2% | 0.00% | – |
Q4 2019 | $38,000 | -20.8% | 13,132 | 0.0% | 0.00% | – |
Q3 2019 | $48,000 | +17.1% | 13,132 | +29.6% | 0.00% | – |
Q2 2019 | $41,000 | -95.7% | 10,136 | -94.6% | 0.00% | – |
Q1 2019 | $964,000 | +484.2% | 188,691 | +1656.1% | 0.00% | – |
Q1 2014 | $165,000 | – | 10,745 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |